News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Fifth patient level recall for 2010

Fifth patient level recall for 2010

Medsafe has advised the Pharmacy Guild of New Zealand (the Guild) that there will be a patient level recall of one batch of Novo Nordisk’s GlucaGen® Hypokit 1mg injection. This is the fifth recall for 2010.

The GlucaGen® Hypokit 1mg injection is used for the treatment of hypoglycaemia. Patients are required to reconstitute this injection before use. The recall is a result of reported cracks in some of the syringes that are used for reconstitution. Reported cracks may result in leakage or microbial contamination.

Medsafe are asking community pharmacists to contact all patients who have had the affected batch dispensed to them. Patients should return their stock to a pharmacy for a replacement.

Although medicine recalls are at present the subject of litigation with community pharmacist and Guild President, Ian Johnson, the Guild will be advising its members not to delay the recall process for discussions regarding recompense, due to patient safety.

“Community pharmacists’ primary concern is patient safety,” says Ian Johnson, President of the Guild. “As the health professional people see most often, community pharmacists are central to managing such recalls. They take their role as medicines experts very seriously and will ensure their patients are well informed about this recall.”

Pharmacists should keep a record of their time and costs in doing the recall and are advised that they should send a bill to Novo Nordisk for the recall service provided at the company’s request.

The number of units likely to be affected by the problem is low, but the risk to patient safety is high. Only one batch has been distributed in New Zealand. This batch is YW60362 and has an expiry date of November 2011. There are approximately 1,588 units in distribution – units are most likely to be in pharmacies, doctors’ surgeries and at patient level.

This is the fifth medicine recall community pharmacists have been involved with this year, including 27 May’s patient level recall by Mylan NZ of all strengths of Pacific Atenolol tablets.

The Guild has a key role in the current Ministerial review of the medicines recall process and continues to argue that pharmacists must be recompensed for the work involved in such recalls.

“Expecting the work to be done for free is nonsense,” says Guild Chief Executive, Annabel Young.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


Scoop Review Of Books: Making History

Jock Phillips is a pioneering public historian who has sought new ways to communicate history to a wide audience. His autobiographical memoir is a fascinating account of how perceptions of history have changed through his career. More>>

New Budget Arts Funding: Fairer Wage For Grant Artists, Creatives In Schools

The vital contribution and huge value the creative sector brings to New Zealand is recognised in this year’s Budget with $11.157 million over four years for two new initiatives, the Minister for Arts Culture and Heritage Jacinda Ardern said today. More>>


Auckland Region MMR Change: Children To Be Vaccinated For Measles At 12 Months

The first measles, mumps and rubella (MMR) vaccination has been brought forward to 12 months from 15 months in Auckland because of the region’s measles outbreak. More>>


Tapu Te Ranga: Fire Destroys Main Building At Island Bay Marae

There was a large fire at the Tapu Te Ranga Marae in Island Bay early Sunday morning. Firefighters saved the meeting house, but the main building collapsed in the blaze and other surrounding buildings were compromised. More>>




  • Wellington
  • Christchurch
  • Auckland